Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs QAAGZX overlap: 79% of top holdings shared

Bottom line

How much do FHLC and QAAGZX overlap?

79% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 62.7% of FHLC's assets and 57.7% of QAAGZX's. They are largely the same portfolio — owning both adds little diversification.

Updated Nov 22, 2026

Overlap at a glance

FHLCQAAGZX
Weight overlap (top 25)79%
Shared holdings17
Weight in shared holdings62.7%57.7%
Total positions337277
Expense ratio0.084%0.86%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FHLC and QAAGZX have in common

Holding% of FHLC% of QAAGZXOverlap
Eli Lilly & Co13.35%14.06%13.35%
Johnson & Johnson8.93%6.64%6.64%
AbbVie Inc6.42%5.12%5.12%
UnitedHealth Group Inc5.44%5.88%5.44%
Merck & Co Inc4.66%4.00%4.00%
Thermo Fisher Scientific Inc3.09%2.53%2.53%
Amgen Inc3.00%1.80%1.80%
Abbott Laboratories2.66%1.91%1.91%
Gilead Sciences Inc2.34%2.79%2.34%
Bristol-Myers Squibb Co1.93%2.12%1.93%
CVS Health Corp1.92%0.93%0.93%
Intuitive Surgical Inc1.82%1.89%1.82%
Danaher Corp1.80%1.44%1.44%
Vertex Pharmaceuticals Inc1.76%2.26%1.76%
Stryker Corp1.62%1.78%1.62%
Elevance Health Inc1.19%1.54%1.19%
Cardinal Health Inc0.78%1.04%0.78%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Pfizer Inc — 2.06%
  2. Medtronic PLC — 1.59%
  3. McKesson Corp — 1.52%
  4. Regeneron Pharmaceuticals Inc — 1.15%
  5. Cigna Group/The — 1.06%
  6. Boston Scientific Corp — 1.00%
  7. HCA Healthcare Inc — 0.91%
  8. Cencora Inc — 0.83%

Only in QAAGZX

  1. Natera Inc — 1.44%
  2. Guardant Health Inc — 1.22%
  3. Royalty Pharma Plc- Cl A — 0.97%
  4. Tenet Healthcare Corp — 0.94%
  5. Kymera Therapeutics Inc — 0.89%
  6. T. Rowe Price Government Reserve Fund — 0.87%
  7. Protagonist Therapeutics Inc — 0.85%
  8. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeFHLCQAAGZX
Stocks99.7%96.9%
Preferred stock—2.2%
Cash & short-term funds0.2%0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFHLCQAAGZX
US96.5%92.3%
IE2.2%0.8%
GB0.5%1.8%
NL0.1%1.0%
BM0.2%0.7%
DK—0.7%
CA0.2%0.6%
CH0.1%0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FHLC and QAAGZX overlap?
About 79% by weight. 17 securities appear in both funds' top 25 holdings; they make up 62.7% of FHLC's assets and 57.7% of QAAGZX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do FHLC and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, AbbVie Inc, Merck & Co Inc.
Should I own both FHLC and QAAGZX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, FHLC or QAAGZX?
FHLC is broader, with 337 positions versus 277 for QAAGZX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.